UroGen Pharma (NASDAQ: URGN)
UroGen Pharma Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
UroGen Pharma Company Info
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.
News & Analysis
Why Shares of UroGen Pharma Jumped Friday
The company released positive top-line results for two studies for a bladder cancer treatment.
Are These 3 Beaten-Down Biotech Stocks Bargains Now?
Some investors think the market's been too hard on these drugmakers.
Are the Shorts Right About This Clinical-Stage Pharma?
Investors walked away from UroGen Pharma after an article was published by a short-seller, but clinical results appear to favor the company.
3 Stocks the World's Best Investors Are Buying Right Now
Should you follow in their footsteps?
Here's Why the Best Is Yet to Come for UroGen Pharma
A major milestone gets closer with each passing day, but the stock seems to keep heading lower.
3 Top Stocks That Aren't on Wall Street's Radar
Wall Street, and most investors who follow its lead, is overlooking this online bank, pharmaceutical company, and master limited partnership. Investors who are paying attention could score outsized gains by investing ahead of the crowd.
These 3 Small-Cap Healthcare Stocks Reported Big Updates This Month
Axsome Therapeutics, Flexion Therapeutics, and UroGen Pharma gave investors reasons for excitement.
3 International Companies Making Waves in the U.S. Soon
This Canadian midstream company, Canadian winter clothing manufacturer, and Israel-based pharma company could soon be making names for themselves in the U.S.
Valuation
Earnings Transcripts
UroGen Pharma Ltd. (URGN) Q3 2020 Earnings Call Transcript
URGN earnings call for the period ending September 30, 2020.
UroGen Pharma Ltd. (URGN) Q2 2020 Earnings Call Transcript
URGN earnings call for the period ending June 30, 2020.
UroGen Pharma Ltd. (URGN) Q1 2020 Earnings Call Transcript
URGN earnings call for the period ending March 31, 2020.
UroGen Pharma Ltd. (URGN) Q4 2019 Earnings Call Transcript
URGN earnings call for the period ending December 31, 2019.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.